Post Reply
1021-1040 of 1197
0.128 ? Think will go to 0.12. As Singaporean do not trust the valuation of its investment. as income. Just like Noble
sheerluck ( Date: 07-Mar-2018 14:19) Posted:
|
Long term support of 13.3cts broken. Now is this a temp break or the start of a new price range.
Weak holders are still dumping I can sense, cutting loss.... Once it tapper down, it should gain back it's momentum. Ready to collect if it weaken but don't see much downside from 13.4/13.5 unless the broader market plunge more..... LOL
13.4 to 13.8 considered good entry price... Won't loss sleep over this. The Israelis are smart people. We just invest to collect the fruits once it bear ......
blurtrader ( Date: 02-Mar-2018 10:22) Posted:
|
good luck to u
NextEvolution ( Date: 02-Mar-2018 09:32) Posted:
|
To sleep well, load this darling, oops! Why did I promote my darling?? ..... Don't miss the boat before it charge back to 15.x near term
My second entry to load up this wacked down darling. Potential is there, and at an unbelievable low price to collect at 13.4 to 13.6 range. Suitable for mid to longer term holding
The company focus on technolgy based medical and agriculture companies that improve the human conditions. I think this is the right direction and the growth potential is there.
Yesterday many rushed to load from 14.3 all the way to 14.8..... LOL
Today neglected counter but good to load at current low 14 price up to 15.x. This is a growth stock for future return, both capital and future dividend play
Today neglected counter but good to load at current low 14 price up to 15.x. This is a growth stock for future return, both capital and future dividend play
Bought a little today. Results good.
THE Trendlines Group swung to a profit of US$3.95 million for the full year ended Dec 31, 2017, from a net loss of US$6.6 million in 2016, on the back of fair value gains to its investments in portfolio companies.
Earnings per share was 1 US cent, up from a 1 US cent-per-share loss a year ago, said Trendlines, an Israel-based company that invests in technology-based companies in the medical and agricultural fields. Net asset value per share stood at 15 US cents as at Dec 31, 2017, unchanged from a year earlier.
The stock last traded on Feb 21 at 14.1 Singapore cents apiece, up 0.1 Singapore cent or 0.71 per cent.
The company raised the fair value of its portfolio to US$96.8 million at the end of 2017, up from US$83.7 million at the end of the previous year, following the completion of fundraising exercises at favourable terms to the portfolio companies and on the back of commercial and technological progress at some of the portfolio companies.
great results?
...becoz the saying " sell on News buy on rumours" ...lol
MarketSensors ( Date: 30-Jan-2018 11:39) Posted:
|
Despite so much good news and yet trend lines still trending down! 😭 😅
It is a lj kor. Avoid!!!!
Battle123 ( Date: 17-Jan-2018 22:09) Posted:
|
Notice many counters stagnant for quite some time
Hopefully can fly up
See how
Hopefully can fly up
See how
Is there any chance for this counter to announce good market growth? it has low volume transacted and the price has stagnant!!
It is buy time !
Is this news going to make trend lines Cheong tmr?
http://infopub.sgx.com/Apps?A=COW_CorpAnnouncement_Content& B=AnnouncementToday& F=C2W4VJ5INAHC2V6G& H=d79b5242242e4cdc5e8f33a6400850475897735aad00db97ba373f455b8262fd& fileId=STS%20Medical%20Receives%20FDA%20Regulatory%20Clearance.pdf
http://infopub.sgx.com/Apps?A=COW_CorpAnnouncement_Content& B=AnnouncementToday& F=C2W4VJ5INAHC2V6G& H=d79b5242242e4cdc5e8f33a6400850475897735aad00db97ba373f455b8262fd& fileId=STS%20Medical%20Receives%20FDA%20Regulatory%20Clearance.pdf
Minor correction has stopped at last defence level of 0.144 and it is time to move up. Cheers!!!
Price above short-term moving averages c/w MACD crossesover signal line as well as histogram is in bullish zone. All these are positive sign and price should be moving up.